TOTAL CONSENT
LIVE

Serial Number

97507248

Owner

Medable, Inc.

Attorney

Omar M. Wadhwa

Filing Date

Jul 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TOTAL CONSENT Trademark

Serial Number: 97507248

TOTAL CONSENT is a trademark filed by Medable, Inc. on July 18, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Medable, Inc. (58 trademarks)

555 Bryant St. #561
Palo Alto, CA 94301

Entity Type: 03

Trademark Details

Filing Date

July 18, 2022

Registration Date

Not Registered

Published for Opposition

December 6, 2022

Goods & Services

Software as a service (SaaS) services featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing telemedicine services; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SaaS) services featuring software for allowing clinical trial participants to provide electronic consent and withdraw electronic consent; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing telemedicine services; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for allowing clinical trial participants to provide electronic consent and withdraw electronic consent

Downloadable software for operating and managing clinical trials by third parties; downloadable software for providing telemedicine services; downloadable software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Downloadable software for allowing clinical trial participants to provide electronic consent and withdrawn electronic consent

Filing History

TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 8, 2025 EPPA
SOU TEAS EXTENSION RECEIVED
Nov 25, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 30, 2025 EX4G
SOU EXTENSION 4 FILED
May 30, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 27, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 27, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 31, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 30, 2024 EX2G
SOU EXTENSION 2 FILED
May 30, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 29, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 16, 2023 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 5, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 31, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 31, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 31, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 31, 2022 CNEA
ASSIGNED TO EXAMINER
Oct 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2022 NWOS
NEW APPLICATION ENTERED
Jul 21, 2022 NWAP